This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Adeza Biomedical Corporation, Toray Industries, Inc., Other. Active years: 1997-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1997-2001
Title: Naohiro Kanayama: Innovator in Medical Applications
Introduction
Naohiro Kanayama is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of medical science, particularly in the area of immunology. With a total of 3 patents to his name, Kanayama's work focuses on enhancing the effects of interleukin-8, a crucial cytokine in the immune response.
Latest Patents
One of Kanayama's latest patents is an agent for potentiating the effect of interleukin-8. This invention comprises dehydroepiandrosterone sulfate or a pharmaceutically acceptable salt as an active ingredient. The agent works by activating the receptor of interleukin-8 and increasing the number of receptors, thereby enhancing its effects. Another significant patent involves a method for promoting conception by administering interleukin-8 or MCAF, showcasing his innovative approach to reproductive health.
Career Highlights
Throughout his career, Kanayama has worked with prominent companies such as Adeza Biomedical Corporation and Toray Industries, Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical technology.
Collaborations
Kanayama has collaborated with esteemed colleagues, including Toshihiko Terao and David C. Casal. These partnerships have further enriched his research and development efforts, leading to impactful innovations in the medical field.
Conclusion
Naohiro Kanayama's contributions to medical science through his patents and collaborations highlight his role as a significant innovator. His work continues to influence the field of immunology and reproductive health, making a lasting impact on medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile